Maxim Group analyst Michael Okunewitch maintained a Buy rating on Mind Medicine (MNMD – Research Report) yesterday and set a price target ...

Lives will be lost because of a shortage of specialist medicine used to detect diseases such as breast and bowel cancer. That ...

Adaptive Biotechnologies will host a conference call to discuss its third quarter 2024 financial results after market close ...

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...

Proposals that would create a new midlevel practitioner (MLP) role raise serious concerns about the future of quality care ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Europeans may not like the Republican candidate, but officials from several countries said his reelection could spur change ...

Amber Clemens — a self-described “former lifelong binge eater” who says she shed 160 pounds from 2018 to 2020 and kept it off ...

Intellia Therapeutics (NASDAQ: NTLA) stands at the forefront of genetic medicine. The company's $2.02 billion market ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Did you know that most of our readers prefer Empower as the best stock alert app? Investing in the stock market helps solve your financial planning puzzle, laying out the pieces for you to use as ...